BIO-TAVI

Anticoagulant Regimens Given to achieve thrombus regression and reduce clinical Outcomes among patients with Non device related intra cardiac thrombus : a randomized Assessment Under direct oral antic...

A phase IV, multicentric, randomized, real-world pragmatic study that compares a strategy of early LDL reduction with anti-PCSK9 in patients defined as extreme high risk by 2019 ESC/EAS guidelines vs....

To demonstrate the non-inferiority of a strategy of simple clinical follow-up (without non-invasive stress testing) in asymptomatic CAD patients with a prior history of coronary revascularization comp...